Bought
Maintained
Sold
Other funds holding NTNX
GIM
BCI
Aviva's NTNX Position: Q1 2026 in Review
Aviva sold out of Nutanix (NTNX) in Q1 2026, closing a stake of 207,120 shares — an estimated $10.7M sold.
Aviva first reported a position in NTNX in Q4 2024 and held it in 5 quarters. The position peaked at $14.3M in Q3 2025. 538 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.
- Aviva reported no remaining Nutanix position as of Q1 2026 after selling out during the quarter.
- Aviva sold 207,120 Nutanix shares in Q1 2026, an estimated $10.7M.
- Aviva first reported a position in Nutanix in Q4 2024 and held it in 5 quarters.
- Aviva's Nutanix position peaked at $14.3M in Q3 2025.
- 538 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.
Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.